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ABSTRACT
Wnt/b-catenin signaling promotes neural differentiation by
activation of the neuron-specific transcription factors,
Neurogenin1 (Ngn1), NeuroD, and Brn3a, in the nervous
system. As neurons in cranial sensory ganglia and dorsal
root ganglia transiently express Ngn1, NeuroD, and Brn3a
during embryonic development, we hypothesized that Wnt
proteins could instructively promote a sensory neuronal
fate from mesenchymal stem cells (MSCs) directed to dif-
ferentiate into neurons. Consistent with our hypothesis,
Wnt1 induced expression of sensory neuron markers
including Ngn1, NeuroD, and Brn3a, as well as glutamater-
gic markers in neurally induced MSCs in vitro and
promoted engraftment of transplanted MSCs in the inner
ear bearing selective loss of sensory neurons in vivo. Given
the consensus function of T-cell leukemia 3 (Tlx3), as a glu-
tamatergic selector gene, we postulated that the effects of
canonical Wnt signaling on sensory neuron and glutamater-
gic marker gene expression in MSCs may be mediated by
Tlx3. We first confirmed that Wnt1 indeed upregulates
Tlx3 expression, which can be suppressed by canonical Wnt
inhibitors. Next, our chromatin immunoprecipitation assays
revealed that T-cell factor 3/4, Wnt-activated DNA binding
proteins, interact with a regulatory region of Tlx3 in MSCs
after neural induction. Furthermore, we demonstrated that
forced expression of Tlx3 in MSCs induced sensory and
glutamatergic neuron markers after neural induction.
Together, these results identify Tlx3 as a novel target for
canonical Wnt signaling that confers somatic stem cells
with a sensory neuron phenotype upon neural induction.
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INTRODUCTION
Mesenchymal stem cells (MSCs) possess several unique prop-
erties that make them a particularly attractive source of cells
for cell-based therapy. MSCs have the potential to self-renew
and differentiate into multiple cell types [1, 2] and have been
used to replace damaged cells in the nervous system using
animal models of neurological disorders or traumatic brain
injury [3, 4]. Recent evidence suggests that MSCs can be
used not only to replace damaged neurons but also to promote
endogenous neuronal cell repair or survival by releasing
neurotrophic factors [5–7]. These results demonstrate multiple
characteristics of MSCs that promote them as donor cells for
cellular repair as well as, potential delivery vectors for thera-
peutic agents.
We previously demonstrated that Sonic hedgehog (Shh)
and retinoic acid (RA) synergistically promote expression of
sensory neuron markers, including GATA3, Sox10, glutamate
receptor 4 (GluR4), and purinergic receptor P2X, ligand-gated
ion channel 3 (P2X3) in MSCs directed to differentiate into
neurons. However, Shh and RA failed to induce expression of
the POU-domain transcription factor Brn3a, which is
expressed in the majority of peripheral sensory neurons during
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development [8–10]. Surprisingly, a conditioned medium pre-
pared from embryonic day10 (E10) mouse hindbrain/somite/
otocyst induced expression of Brn3a, as well as, Ngn1, and
NeuroD [11]. The effects of the conditioned medium appeared
to be specific, as no change in the GATA3 or Sox10 expres-
sion level was detected. These results prompted us to postu-
late that a soluble protein(s), other than Shh or RA, in the
conditioned medium could regulate Brn3a, Ngn1, and NeuroD
in MSCs.
Several lines of evidence suggest that Wnt signaling plays
pivotal roles in cell fate specification in the nervous systems.
Wnt genes encode secreted glycoproteins that exert diverse
functions during embryogenesis depending on the cellular and
developmental contexts. Canonical Wnt signaling allows b-
catenin to translocate to the nucleus, where it interacts with
T-cell factor (TCF) family of DNA-binding proteins and regu-
late transcription [12–14]. Neural crest progenitor cells were
shown to acquire Brn3a expression at the expense of Sox10
expression by Wnt/b-catenin signaling [15, 16]. Furthermore,
Wnt signaling is essential for generation of otic progenitor
cells, some of which give rise to auditory sensory neurons, at
early stages of inner ear development [17, 18]. Wnt has also
been shown to promote neuronal differentiation from embry-
onic, somatic, and neural stem cells [19–21]. On the basis of
these previous studies, we hypothesized that Wnts are the
soluble proteins in the conditioned medium, which promote




MSCs were isolated from the femurs and tibias of 5- to 7-week
old C57BL/6 wild-type mice (Jackson Lab, Bar Harbor, ME),
maintained as described previously [11, 22]. These MSCs
expressed common MSC markers, but lacked expression of hema-
topoietic cell markers [22]. Some of the cultured MSCs were
plated on poly-D-lysine-coated culture dishes at 5  104 cells per
centimeter square. To initiate neural differentiation, culture me-
dium was replaced with neural induction medium containing Dul-
becco’s modified Eagle medium, 10 ng/ml fibroblast growth fac-
tor 2 (Peprotec, Rocky Hill, NJ), 2% B27 (Invitrogen, Carlsbad,
CA), 5 lM Forskolin (Sigma, St.Louis, MO), 125 lM 3-isobutyl-
1-methylxanthine (Sigma,) with 10 lM b-mercaptoethanol, and
one of the following reagents: (a) recombinant human Wnt1 (1–
400 ng/ml; Peprotec, Rocky Hill, NJ), (b) recombinant human
Wnt3a (1–400 ng/ml; R&D Systems, Minneapolis, MN), (c) no
factor (control). The cells were incubated for an additional 3 or 7
days. In function-blocking experiments, recombinant mouse Dkk1
(1–100 lg/ml; R&D Systems) or recombinant mouse sFRP2
(0.1–500 ng/ml; R&D Systems) were added to neural induction
medium containing Wnt1 (100 ng/ml) prior to the start of an
incubation period.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation was performed using the Chip-IT
Express kit (Active Motif, Carlsbad, CA) according to the manu-
facture’s instructions. MSCs were incubated for 4 days in mainte-
nance medium, followed by neural induction medium in the pres-
ence or absence of 100 ng/ml Wnt1. Cells were incubated for an
additional 2 days, after which nuclear protein and genomic DNA
were cross-linked by incubation with 1% formaldehyde. The
nuclei were collected by Dounce homogenization and centrifuga-
tion, and sonicated to shear chromatin to an average of 200- to
800-bp fragments. Immunoprecipitations were performed with
anti-TCF3/4 antibody (Millipore, 6F12-3, Billerica, MA) or the
corresponding preimmune serum using Protein G magnetic beads.
The isolated DNA was subjected to polymerase chain reaction
(PCR) analyses using primers flanking the TCF binding sites in
the Tlx3 promoter and its 30 noncoding region. A sample repre-
senting 0.5% of the total chromatin used for immunoprecipitation
reactions was used as an input control. A primer pair for the
CyclinD1 promoter [23] was used as a positive control, whereas a
primer pair for region 1 (Fig. 5D) that does not contain the TCF-
binding motif in the Tlx3 regulatory region was used as a nega-
tive control. PCR products were resolved on 2% agarose gels and
visualized using ethidium bromide staining. The identity of PCR
products was confirmed by cloning DNA fragments into pCR
vectors (Invitrogen) and sequence analysis.
Luciferase Reporter Assays
Reporter constructs were prepared using the pGL3 vector (Prom-
ega, Madison, WI) that contains a Firefly luciferase reporter gene.
A PCR fragment containing the 2,849-bp sequence lying
upstream of the Tlx3 start codon was cloned into the pGL3 vec-
tor. A mutation in the Tlx3 promoter was introduced using the
QuickChange Site-Directed Mutagenesis kit (Stratagene, LA
Jolla, CA). For the luciferase reporter assay, MSCs were cotrans-
fected with the Tlx3 promoter-reporter plasmid (wild-type or mu-
tant construct) and the pGL4.74 [hRluc/TK] plasmid encoding
Renilla luciferase (Promega). Transfected cells were grown in
neural induction medium containing Wnt1 (400 ng/ml) for 3
days. Luciferase activity was measured using the dual luciferase
assay system (Promega). Firefly luciferase activity was normal-
ized relative to the activity of Renilla luciferase.
Surgery and Cell Implantation
Mongolian gerbils (Charles River, Wilmington, MA) at the age
of 4-month old were used in this study. The experimental proto-
col for this study was approved by the institutional animal care
and use committee at the Indiana University School of Medicine.
Surgery procedures have been previously described [24, 25].
Briefly, following anesthesia, an incision was made to expose the
left posterior side of the skull. A piece of gelform (Pfizer, New
York, NY) soaked with 5 ll ouabain was placed in the round
window niche. The animals were allowed to recover for 1 month,
during which progressive degeneration of spiral ganglion neurons
takes place. Following the recovery period, the animals were
anesthetized and a suspension of cultured MSCs (1  106 cells
per microliter) in 10 lL phosphate-buffered saline (PBS) (left
ear) or 10 lL PBS (right ear, control) was injected into the mod-
iolus through a 30-gauge needle that was inserted into the bony
wall of the basal turn of the cochlea.
An Alzet mini-osmotic pump (Model 2004) was used to
deliver neural induction medium and Wnt1. The flow rate for
infusion at 37C was 0.25 ll/hour. Under the sterile condition,
the osmotic pump was loaded with neural induction medium that
contained five times higher concentrations of agents than the one
used for in vitro experiments. The osmotic pump was placed in a
37C saline bath for 12 hours, which allowed the pump to be
fully functional immediately upon implantation. The infusion tip
of the cannula was made by stripping the Teflon coating from
36-gauge platinum iridium wire (Cooner Wire Co., Chatsworth,
CA). A 1.25-cm piece of this Teflon Tubing (0.13-mm inner di-
ameter [ID]; 0.18-mm outer diameter [OD]) was inserted into the
end of a 12-mm polyurethane tubing (0.64-mm ID; 1.10-mm OD)
(Micro-Renathane, Braintree Scientific Inc., Braintree, MA) and
secured with silicon rubber (Dow Corning, MDX 4-4210), leav-
ing 6 mm as a fine infusion tip (Supporting Information Fig. 1).
Seventy-two hours after the implantation, the osmotic pump was
changed to a new pump containing 500 ng/ml Wnt1 and 250 ng/
ml brain-derived neurotrophic factor (BDNF) under general anes-
thesia. The animals carried the second osmotic pump for the fol-
lowing 3 weeks, after which they were euthanized and their tem-
poral bones were processed for immunohistochemistry.
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RESULTS
Sensory Neuron Markers and Glutamate Receptors
in Neurally Induced MSCs are Upregulated by
Wnt1 in a Dose-Dependent Manner
As the Wnt receptors Frizzled (Fz) and low-density lipoprotein
receptor-related protein 5/6 as well as key Wnt signaling com-
ponents are constitutively expressed in MSCs [26], we first
tested whether canonical Wnt ligands can upregulate sensory
neuron markers in MSCs after neural induction. Incubation of
MSCs in neural induction medium supplemented with human
recombinant Wnt1 (1–400 ng/ml) for 7 days resulted in a sig-
nificant upregulation of Ngn1, NeuroD, Brn3a, and P2X3, and
the effects of Wnt1 were dose-dependent (Fig. 1). Wnt1 at 10
ng/ml or less had little effect on gene expression levels,
whereas Wnt1 at 100 and 400 ng/ml induced robust upregula-
tion of all sensory neuron markers examined. Recombinant
Wnt3a exhibited similar but lesser effects than Wnt1 (Support-
ing Information Fig. 2). Interestingly, when MSCs were cul-
tured in maintenance medium, Wnt1 did not induce any of
Ngn1, NeuroD, or Brn3a (Supporting Information Fig. 3). We
also tested the effects of Wnt1 on AMPA receptors (GluR1-4)
and found that all AMPA receptors were significantly upregu-
lated in MSCs grown in neural induction medium containing
Wnt1 (Fig. 1 and Supporting Information Fig. 4A). Consistent
with the RT-PCR data, Brn3a, GluR4, and VGLUT2 proteins
were detected in MSCs grown in neural induction medium
with Wnt1 but not in those grown in maintenance medium with
Wnt1 (Fig. 2A–2F). In contrast to the sensory neuron marker
genes, expression of pan-neural marker genes, such as Tau and
TUJ1, was not altered by Wnt1 in neurally induced MSCs (Fig.
1). Likewise, expression of dopaminergic- (TH, Nurr1),
GABAergic neuronal subtype markers (Grik2, Viaat), glial
markers (glial fibrillary acidic protein [GFAP], Integrin beta 4
[Itgb4]) was unresponsive to Wnt1 (Supporting Information
Fig. 4B). Flow cytometric analysis was performed to quantita-
tively compare expression of CD24 (pan-neural surface
marker; [27]) and GluR2 between MSCs grown in the presence
or absence of Wnt1 (Fig. 2G, 2H). The percentage of MSCs
expressing CD24 increased dramatically after culture in neural
induction medium for 7 days, but there was no significant dif-
ference in the percentage of CD24-positive cells between
MSCs grown in neural induction medium only and those grown
in neural induction medium containing Wnt1. In contrast, the
percentage of GluR2-positive cells in neurally induced MSCs
grown in the presence of Wnt1 (53.0%) was much greater than
undifferentiated MSCs (2.2%) as well as neurally induced
MSCs in the absence of Wnt1 (12.9%). As CD24 is expressed
not only in neurons but also in granulocytes [28, 29], we tested
a possible enrichment of granulocyte precursors in our culture
using the hematopoietic markers, CD34, 117, and Sca1 (Sup-
porting Information Fig. 5). The percentage of neurally induced
MSCs expressing CD34, 117, or Sca1 was less than 5% and
there was no difference in the percentage between cells grown
with or without Wnt1, ruling out the possibility that Wnt1
promotes hematopoetic cell proliferation or differentiation.
To test whether Wnt1-induced upregulation of the sensory
marker genes in MSCs can be suppressed by specific canoni-
cal Wnt inhibitors, MSCs were incubated in neural induction
medium supplemented with Wnt1 (100 ng/ml) and either
Dkk1 (1–100 ng/ml) or secreted frizzled-related protein 2
(sFRP2) (1-500 ng/ml) for 7 days (Fig. 3). Both Dkk1 and
sFRP2 efficiently suppressed Wnt1-induced upregulation of
Ngn1, NeuroD, and Brn3a. Furthermore, Wnt1-induced upreg-
ulation of Cyclin D1, a known Wnt target, was suppressed by
Dkk1 or sFRP2 at both transcriptional and protein levels (Fig.
3 and Supporting Information Fig. 6). To test whether Dkk1
and/or sFRP2 have any toxic effects on cell viability or can
silence genes nonspecifically, we examined expression of Tau
and TUJ1, whose expression is not regulated by Wnt1. No
significant changes in expression levels of these neural marker
genes were observed in cells treated either with Dkk1 or
sFRP2 even at the highest concentration used.
The canonical Wnt signaling pathway regulates b-catenin
stability through Fz and LRP coreceptors. When Wnt ligands
bind Fz and LRP, phosphorylation of b-catenin is inhibited,
causing b-catenin stabilization, and translocation into the cel-
lular nucleus. Using Western blot analysis, we evaluated
changes in total and phosphorylated b-catenin expression in
MSCs in response to Wnt1 stimulation (Fig. 4A). MSCs were
cultured in neural induction medium in the presence or ab-
sence of Wnt1 for 1 or 3 days. Expression of total b-catenin
was increased by Wnt1, while expression of phospho-b-cate-
nin was decreased. Furthermore, nuclear and cytoplasmic pro-
tein fractions were extracted from neurally induced MSCs
Figure 1. Wnt1 induces sensory neuron marker and AMPA receptor
genes in neurally induced mesenchymal stem cells (MSCs). qRT-PCR
analysis for sensory neuron markers (Ngn1, NeuroD, Brn3a, and
P2X3), glutamate receptors (GluR2 and GluR4), and pan-neural
markers (Tau and TUJ1) in MSCs grown in neural induction medium
with recombinant human Wnt1 (1–400 ng/ml) for 7 days. Values are
mean 6 SD. *, p < .05; **, p < .001.
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that had been grown in the presence or absence of Wnt1 for 3
days (Fig. 4B). Total b-catenin in the nucleus was signifi-
cantly higher in MSCs grown in the presence of Wnt1 than
those devoid of Wnt1. In contrast, expression of phosphoryl-
ated b-catenin in the cytoplasm was significantly lower in
MSCs exposed to Wnt1 compared with those not exposed to
Wnt1. These results indicate that stimulation of the canonical
Wnt signaling pathway in neurally induced MSCs promotes
dephosphorylation of cytoplasmic b-catenin and its transloca-
tion into the nucleus. Consistent with our qRT-PCR results
(Fig. 1), an increase in the GluR4 level and no changes in the
TUJ1 level were observed when MSCs were grown in
the presence of neural induction medium containing Wnt1
(Fig. 4A).
Tlx3 Is Upregulated Directly by Canonical Wnt
Signaling
T-cell leukemia 3 (Tlx3) is a selector transcription factor pro-
moting an excitatory glutarmatergic neuronal phenotype over
Figure 2. Sensory and glutamatergic neural markers are expressed in neurally induced MSCs in the presence of Wnt1. Immunohistochemical charac-
terization of MSCs grown in maintenance medium (A–C) and neural induction medium containing Wnt1 for 7 days (D–F). (A–F): TUJ1, NF, and VG2
immunofluorescence is shown in green. Synp, Brn3a, and GluR4 immunofluorescence is shown in red. Cells are counterstained with DAPI (blue). Scale
bar ¼ 100 lm. (G, H): Flow cytometry profiles of CD24-PE and GluR2-Alexa 568 fluorescence in undifferentiated MSCs and MSCs at MSCs-NI7 or
MSCs-NI7þWnt1. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; MSC, mesenchymal stem cell; VG2, VGULT2; MSCs-NI7, MSCs at neural
induction day 7 withoutWnt1; MSCs-NI7þWnt1, MSCs at neural induction day 7 withWnt1.
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an inhibitory GABAergic phenotype during dorsal spinal cord
development [21, 30, 31]. We recently demonstrated that
forced expression of Tlx3 is sufficient to induce ectopic
expression of glutamatergic neuron markers in ESC-derived
neurons [32]. Moreover, Tlx3 expressing ESC-derived neu-
rons exhibit excitatory neuronal functions, such as action
potentials and excitatory postsynaptic currents. On the basis
of the function of Tlx3 as a master selector gene [30] as well
as the overlapping set of genes upregulated by Wnt1 and by
Tlx3 (Fig. 1; [32]), we hypothesized that the effects of canon-
ical Wnt signaling on expression of an array of sensory and
glutamatergic marker genes in MSCs may be mediated, at
least in part, by Tlx3. To validate this hypothesis, we first
tested if Tlx3 expression in MSCs can be regulated by canon-
ical Wnt signaling. Incubation of MSCs in neural induction
medium containing Wnt1 increased the Tlx3 mRNA level in a
dose-dependent manner and the Wnt1-induced upregulation
of Tlx3 was suppressed by Dkk1 as well as by sFRP2
(Fig. 5A, 5B).
To determine whether TCF3/4, Wnt-activated DNA bind-
ing proteins, interact with the regulatory regions of Tlx3, we
conducted chromatin immunoprecipitation assays. DNA from
the immunoprecipitated complex with an anti-TCF3/4 anti-
body was analyzed by PCR using six primer pairs that span
potential regulatory regions containing a consensus TCF-
binding sequence (A/T A/T CAAA) [21] and could therefore
serve as a binding site for TCF3/4. A promoter region of
Cyclin D1 was used as a positive control. Positive binding
of TCF3/4 to a region approximately 540-bp upstream of
the Tlx3 start codon (region 3) was detected in neurally
induced MSCs grown in the presence of Wnt1 but not in
those in the absence of Wnt1 (Fig. 5C–5D). Sequence analy-
sis of PCR products for the region 3 validated that the
immunoprecipitated chromatin indeed contained sequences in
this promoter region. All other Tlx3 regulatory regions con-
taining a consensus TCF-binding sequence exhibited a lack
of binding with TCF3/4. To determine whether the TCF
binding site that we have identified (region 3 in Fig. 5C) is
functional, we compared the activities of the Tlx3 promoter
(nt 2,577 to þ272) containing either an intact (TTTGTT)
or mutated (TTTGGC) sequence (Fig. 5E). The Tlx3 pro-
moter was cloned into a pGL3 luciferase reporter vector
and, using a site-specific mutagenesis kit, another reporter
construct with a mutation in the TCF-binding motif was
generated. MSCs were transfected with these reporter con-
structs and incubated in neural induction medium containing
Wnt1 (400 ng/ml) for 4 days. Consistent with the results
from chromatin immunoprecipitation assays, the Tlx3 pro-
moter activity was significantly reduced with a mutation in
the region 3 TCF-binding site, when compared with a wild-
type (Fig. 5F). Notably, the promoter activity of the Tlx3
mutant was significantly higher than that of the negative
control pGL3-basic vector lacking any promoter sequence.
This could be attributed to nuclear factor Y (NFY)-
Figure 3. Wnt antagonists suppress Wnt1-induced induction of Ngn1, NeuroD, and Brn3a in MSCs. qRT-PCR for Ngn1, NeuroD, Brn3a,
CyclinD1, Tau, and TUJ1 in MSCs grown in neural induction medium with recombinant human Wnt1 and either Dkk1(1–100 ng/ml) or sFRP2
(1–500 ng/ml) for 7 days. Abbreviations: MSC, mesenchymal stem cell; sFRP2, secreted frizzled-related protein 2.
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dependent basal promoter activation as the mutant Tlx3 pro-
moter contains NFY-binding sites, which are critical for ba-
sal Tlx3 expression [33].
Ectopic Expression of Tlx3 in MSCs Induces
a Sensory Neuron Phenotype
To test whether Tlx3 can regulate expression of those genes,
which are regulated by Wnt1, MSCs, which do not constitu-
tively express Tlx3, were transfected with a Tlx3 expression
vector (pBud-eGFP-cTlx3) or a control vector (pBud-eGFP).
MSCs stably expressing the Tlx3 expression construct or con-
trol construct were subjected to neural induction. Despite dra-
matic changes in cell morphology, intense GFP fluorescence
was maintained in virtually 100% of neurally induced MSCs,
indicating that transgene expression was not silenced by neu-
ral induction (Fig. 6A). Consistent with this, high-level Tlx3
expression was detected in MSCs expressing pBud-eGFP-
cTlx3, but not in untransfected MSCs or MSCs expressing
pBud-eGFP (Fig. 6B–6C).
qRT-PCR analyses were performed to evaluate changes in
gene expression in neurally induced MSCs in response to ec-
topic Tlx3 expression. Pan-neural markers, such as Tau,
TUJ1, and Synp, were induced after neural induction, how-
ever, no significant differences in their expression levels were
observed in the presence or absence of Tlx3. In contrast,
expression levels of Ngn1, NeuroD, Brn3a, Mash1, and
GluR4 in Tlx3-expressing MSC-derived cells were signifi-
cantly higher than in control MSC-derived cells at neural
induction day 4 (Fig. 6D). In addition, Brn3a, Mash1, and
GluR4 expression remained elevated in cells expressing Tlx3
at neural induction day 7, and a notable upregulation of the
Figure 4. b-catenin in mesenchymal stem cells (MSCs) is dephos-
phorylated and translocated in response to Wnt1 after neural induction.
(A):Western blot analysis for total b-catenin and P-b-catenin, GluR4,
and TUJ1 in MSCs at 1, 3 days after neural induction with (þ) or
without () recombinant human Wnt1. b-actin is used as a loading
control. (B): Expression of b-catenin and P-b-catenin in the nuclear
and cytoplasmic extracts from neurally induced MSCs with Wnt1 for 3
days. RNA polII was used as an internal control for the nuclear protein
fraction. Abbreviation: P-b-catenin, phosphorylated b-catenin.
Figure 5. Tlx3 is upregulated directly by canonical Wnt signal-
ing. (A, B): qRT-PCR analysis for Tlx3 in MSCs at day 7 of
neuron induction with Wnt1 and either Dkk1 (1, 10, or 100 ng/
ml) or sFRP2 (1, 10, or 100 ng/ml). (C, D): Chromatin immuno-
precipitation with anti-TCF3/4 antibody on the resulting genomic
DNA was conducted on neurally induced MSCs. Polymerase chain
reaction probes to the various promoters relative to the Tlx3 cod-
ing region are indicated in (C). The red vertical lines indicate the
positions of a consensus TCF-binding sequence. (D): The pro-
moter region 3 exhibits binding with TCF3/4 in the presence of
Wnt1, whereas other regions lack binding. Cyclin D1 promoter, a
known TCF target, was used as a positive control. IgG represents
the amount of DNA immunoprecipitated by normal mouse IgG
(negative control). Input DNA represents a sample representing
0.5% of the total chromatin used for immunoprecipitation reac-
tions (input control). (E): pLG3 luciferase reporter vector contain-
ing Tlx3 promoter (WT) and its mutant within the region 3 TCF-
binding site (Mt). (F): Relative luciferase activity in pLG3 control
vector (Ctrl), Tlx3 promoter (WT), and mutant Tlx3 promoter
(mt) expressing neurally induced MSCs with Wnt1 for 3 days. *,
p < .05; **, p < .001. Abbreviations: Dkk1, Dickkopf-related
protein 1; MSC, mesenchymal stem cell; Mt, mutant; sFRP2,
secreted frizzled-related protein 2; TCF 3/4, T-cell factor, 3/4;
WT, wild type.
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glutamate transporter VGLUT2 was observed in MSC-derived
cells expressing Tlx3 but not in those expressing the control
vector. The downregulation of Ngn1 and NeuroD at neural
induction day 7 as compared with day 4 (Fig. 6D) is consist-
ent with transient expression of these proneural genes in
neural progenitor cells in vivo. Furthermore, the delayed up-
regulation of GluR4 and VGLUT2 in neurally induced MSCs
expressing Tlx3 coincides with that observed during embry-
onic neural differentiation.
Wnt1 Promotes Engraftment and Differentiation of
MSCs in an Animal Model of Auditory Neuropathy
The positive effects of Wnt1 on MSC differentiation in vitro
prompted us to test its effect on MSCs in vivo. We
hypothesized that engraftment and neuronal differentiation
would be enhanced if MSCs are implanted into the cochlea
of animals bearing selective loss of auditory sensory neurons
and subsequently exposed to neural induction medium and
Wnt1 in situ. GFP-positive MSCs isolated from TgN(ACT-
bEGFP) mice were subjected to preinduction and then
implanted into eight Mongolian gerbils, deafened by ouabain
[25, 34]. A modified ALZET osmotic pump was used to
continuously infuse (a) neural induction medium for 3 days
followed by Wnt1 and BDNF for 25 days (experimental
group), (b) neural induction medium followed by BDNF
alone (control one group), or (c) physiological saline for
28 days (control two group) into the implanted cochlea
(Fig. 7A). After 28 days postimplantation, a very small
number of MSCs were found in the cochlea of control
Figure 6. Forced expression of Tlx3 results in upregulation of sensory and glutamatergic marker genes in neurally induced MSCs. (A): Forced
expression of Tlx3 in MSCs. Virtually 100% of MSCs expressing pBud-eGFP-cTlx3 in the figure are GFP-positive and remain stably exhibiting
GFP expression after neural induction. Scale bar ¼ 100 lm. (B, C): RT-PCR analysis for GFP and Tlx3 in neurally induced MSCs-expressing
pBud-eGFP (GFP) or pBud-eGFP-cTlx3 (Tlx3). (D): qRT-PCR analysis for Ngn1, NeuroD, Brn3a, Mash1, GluR4, VGLUT2, Tau, TUJ1, and
Synp in MSCs expressing the Tlx3 expression vector (Tlx3) in comparison with those expressing the control vector (GFP). Undifferentiated
MSCs (CT) or MSCs grown in neural induction medium for 4 days (NI4) or 7 days (NI7). **, p < .001. Abbreviations: CT, control; GFP, green
fluorescent protein; MSC, mesenchymal stem cell; NI7, neural induction day 7; NI4, neural induction day 4; NC, no cDNA; PC, E10 otocyst.
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Figure 7. Wnt1 promotes engraftment and differentiation of mesenchymal stem cells (MSCs) in the gerbil cochlea with selective loss of spiral
ganglion neurons. (A): Experimental design in in vivo experiments. (B–G): GFP-positive MSCs transplanted into the modiolus of the gerbil coch-
lea that has received physiological saline ([B], control) or neural induction medium followed by Wnt1 (C, D, E, G). The number of average GFP-
positive profiles per section for the control and NI medium and Wnt1 group (NIþWnt1) (F). GFP-positive MSCs (green) are found not only in areas
surrounding the SG in the cochlea but also in the sensory epithelia of the macula in the saccule. Cellular nuclei are stained with DAPI (blue). Coch-
lear structures are visualized with rhodamine-conjugated phalloidin (Pha, red) (B, C). NF and TUJ1 immunofluorescence are shown in red (D, F,
G). Yellow star indicates the stem cell injection site. **, p < .001. Abbreviations: CT, control; DAPI, 40,6-diamidino-2-phenylindole; GFP, green
fluorescent protein; NF, neurofilament; NI, neural induction medium; OC, organ of corti; SG, spiral ganglion.
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animals that had received physiological saline (Fig. 7B, 7F).
In contrast, a significantly greater number of GFP-positive
MSC-derived cells were found in the modiolus of animals
that had received neural induction medium and the number
of engrafted cells was even greater in animals that had
received neural induction medium followed by Wnt1 (Fig.
7C–7G). To test whether the observed difference in the
number of engrafted cells between the experimental and the
control 1 groups is due to the effect of Wnt1 on cell prolif-
eration, we performed in vitro BrdU-incorporation assays
(Supporting Information Fig. 7). The percentages of BrdU-
positive cells in neurally induced MSCs in the presence and
absence of Wnt1 after 24 hours exposure to 10 lM BrdU
were 2.36% and 2.26%, respectively, and these values were
much lower than the percentage of BrdU-positive cells
(76%) in undifferentiated MSCs [11]. Strikingly, GFP-posi-
tive MSCs that had been injected into the basal cochlear
turn were found throughout all cochlear turns and many
were found in areas surrounding the spiral ganglion at 28
days postimplantation, thus indicating extensive migration of
the MSCs throughout the sensorineural tissues of the coch-
lea. Numerous GFP-positive cells were observed areas sur-
rounding the spiral ganglion, while only several MSCs were
detected within the ganglion (Fig. 7D). Some of the GFP-
positive cells exhibited spherical cell bodies with long
neurites and expressed several neural markers, including
neurofilament and TUJ1 (Fig. 7G).
DISCUSSION
MSCs in the bone marrow possess several unique properties
that make them a particularly attractive source of somatic stem
cells for cell replacement therapy. MSCs have a high self-
renewal potential, genetic stability and relative ease of collec-
tion from patients’ own bone marrow. Furthermore, two other
extraordinary characteristics have been recently identified,
including one in our present study, which makes MSCs an
excellent source of cells for autologous transplantation therapy,
that is, MSCs exhibit remarkable abilities to migrate toward
sites of tissue injury and have strong immunosuppressive prop-
erties [35, 36]. In this study, we sought to determine the iden-
tity of microenvironment-derived soluble proteins that promote
specification of MSCs toward a sensory neuron phenotype.
We have demonstrated that Wnt1 and -3a secreted from
the microenvironment surrounding the embryonic inner ear
can instructively promote expression of several sensory neuron
markers, including Ngn1, NeuroD, Brn3a, P2X3, GluR1-4, in
MSCs that are exposed to neural induction signals (Fig. 1 and
Supporting Information Fig. 2). Wnt ligands are secreted gly-
coproteins but are known to be highly hydrophobic and, thus,
tend to adhere the plasma membrane of the secreting cells
[14]. Despite this adherent property, we were able to detect
both Wnt1 and Wnt3a proteins in conditioned medium pre-
pared from the E10 mouse cervical tissues containing the oto-
cyst, hindbrain, and somite (T. Kondo, unpublished observa-
tions). This is consistent with previous reports, in which Wnt4
secreted from COS cells exert attractive cues for responsive
neurons that were located more than 300 lm from Wnt4-
secreting cells [37, 38], suggesting that Wnt proteins can func-
tion as classical diffusible signaling proteins albeit for lesser
spatial ranges. Although we did not measure electrophysiologi-
cal properties of neurally induced MSCs used in this study,
recent studies revealed that MSC-derived cells are capable of
generating action potentials, as well as expressing sodium and
voltage-gated calcium channels [39–41], indicating the compe-
tence of MSCs to give rise to functional neurons.
We also presented evidence that the regulation of the sen-
sory marker genes by canonical Wnt signaling is mediated, at
least in part, by the master selector gene Tlx3. Wnt1 was able to
induce Tlx3 expression in MSCs in a dose-dependent manner
(Fig. 5A). When Tlx3 was introduced in MSCs that do not con-
stitutively express Tlx3, these cells exhibited significantly
higher levels of Ngn1, NeuroD, Brn3a, and GluR4 than those
lacking Tlx3 after neural induction (Fig. 6). Importantly, the up-
regulation of the sensory neuron marker genes in MSCs by
Wnt1 or Tlx3 was context-dependent. Both Wnt1 and Tlx3
instructively promoted expression of the target genes only after
MSCs were exposed to neural induction medium, while they
had no effect on gene expression in untreated MSCs. The con-
text-dependent regulation of gene expression in MSCs by Tlx3
is consistent with our previous results with mouse ESCs [32].
One potential mechanism involved in this process is epigenetic
transcriptional regulation mediated by Pbx3, a member of the
TALE family of DNA-binding proteins. Pbx proteins are
known to function as transcription cofactors and modulate
DNA binding affinity and specificity of HOX proteins, such as
Tlx3 [42, 43]. As most HOX proteins exhibit promiscuous
DNA-binding properties despite their specific transcriptional
activity, it is believed that Pbx proteins enhance target site se-
lectivity by interacting with HOX proteins on the promoter loci
of their target genes [44, 45]. The transcriptional complexes
formed by Pbx and Hox proteins recruit a variety of coregula-
tors. It is possible that some transcriptional coactivators, such
as a histone acetyltransferase, might be recruited upon neural
induction to the Tlx3-Pbx3 heterodimer on the Ngn1 promoter,
thereby inducing chromatin modifications and evoking tran-
scriptional activation of Ngn1. Alternatively, Sox2 might be
involved in the context-dependent Tlx3 actions. In the adult
hippocampus, canonical Wnt signaling activates NeuroD
expression in neural stem cells. The regulatory region of Neu-
roD has binding sites for TCF/LEF and Sox2, some of which
form a Sox2/LEF hybrid binding motif. Wnt signaling directly
control NeuroD transcription through TCF/LEF, but that the
Sox2/LEF element serves as a dual switch either repression by
Sox2 or activation by TCF/LEF [21]. Despite a lack of the
Sox2/LEF hybrid binding site, a Sox2-binding site was detected
in the 30-regulatory region of Tlx3. As Sox2 is expressed in un-
differentiated MSCs, but not after neural induction, it is possi-
ble that loss of Sox2 after neural induction might result in disin-
hibition of TCF-mediated transcriptional activation of Tlx3,
thereby indirectly activating its target genes.
We have identified Tlx3 as a direct downstream target for
canonical Wnt signaling in MSCs that are grown in neural
induction medium containing Wnt1. Ectopic expression of
Tlx3 in MSCs upregulated the same set of genes as those
which were upregulated by Wnt1 (Figs. 1, 6). An increase in
nuclear b-catenin and a reduction in cytoplasmic phosphoryl-
ated b-catenin were observed concomitantly with the specific
binding of TCF3/4 with the Tlx3 promoter. Our sequence
search identified a total of six sites in the Tlx3 regulatory
regions that contain consensus TCF binding motif(s). Of these
putative TCF binding sites, only a region located approxi-
mately 530-bp upstream of the Tlx3 coding region turned out
to exhibit a binding with TCF3/4 and a mutation in this pro-
moter region resulted in impaired Tlx3 promoter activity. The
identification of the functional TCF-binding site reveals that
Tlx3 is a novel Wnt target gene.
It is interesting to note that stimulation of the canonical
Wnt pathway has little effect on the expression levels of
GATA3 or Sox10, both of which are upregulated by a combi-
nation of Shh and RA [11]. Conversely, Shh and RA failed to
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induce expression of Brn3a and NeuroD in MSCs [11], which
are upregulated by Wnt1 or Wnt3a (Fig. 1 and Supporting In-
formation Fig. 2). Several lines of evidence indicate that some
of the genes induced either by Wnt1 or ShhþRA in our prepa-
rations are complementary expressed in neural progenitors dur-
ing development. In the dorsal spinal cord, neural crest-derived
progenitors lose Sox10 expression and give rise to Brn3a-posi-
tive sensory neurons [16]. In the inner ear, NeuroD-positive
progenitor cells lose NeuroD expression and differentiate into
GATA3-positive auditory sensory neurons [46]. Thus, timing
and balance of Wnt proteins and ShhþRA applications may
be a key for instructing neurally induced MSCs to differentiate
into cell populations with a specific phenotype.
Positive effects of Wnt1, when combined with neural
induction medium, on engraftment of MSC-derived cells were
observed in the cochlea of animals with selective loss of spi-
ral ganglion neurons (Fig. 7). As MSCs become postmitotic
after neural induction and as Wnt1 has no effect on cell
growth rate of neurally induced MSCs (Supporting Informa-
tion Fig. 7; [11]), the observed increase in the number of
engrafted cells is most likely due to the effect of Wnt1 on
cell survival. This is consistent with a recently recognized
function of Wnt/b-catenin signaling for survival and mainte-
nance of neural progenitor cells [47–50]. The fact that Wnt1-
induced upregulation of CyclinD1 did not accompany an
increase in cell proliferation in neurally induced MSCs seems
paradoxical. However, the expression level of CyclinD1 in
neurally induced MSCs in the presence of Wnt1 was only
15% of undifferentiated MSCs (Fig. 3). The extent of MSC
migration was also robust, as partially differentiated MSCs
implanted into the basal turn of the cochlea were found to be
present in the apical turn 4 weeks after transplantation. This,
however, is probably due to an innate characteristic of MSCs,
rather than trophic effects of Wnt1, as cell engraftment was
observed only in the basal turn of the cochlea that had
received mouse ESCs (A. Matsuoka, unpublished observa-
tions). Despite the enhanced migration and engraftment, the
rate of engrafted MSCs expressing pan-neural markers was
low (less than 10%). This could be attributed to (a) the short-
infusion period (3 days) with neural induction medium, and
(b) the concentration of neural induction medium was not
high enough to promote neural induction, although we used a
medium that contained five times higher concentrations of
reagents used for our in vitro experiments. Furthermore,
Wnt1, known to exert diverse functions depending on devel-
opmental contexts, might not have promoted neuronal differ-
entiation as neural induction was incomplete in our cell popu-
lations. Wnt proteins have been shown to promote
neurogenesis, neuronal cell fate specification, axon growth,
and synaptic number/transmission depending on cellular and
developmental contexts [16, 38, 51, 52]. In our in vivo exper-
imental paradigm, it would be extremely difficult to control
precise timing and doses of Wnt(s) that MSCs are exposed to
while undergoing neural differentiation. As Wnt signaling-
mediated sensory neuron specification in MSCs is mediated
by Tlx3, Tlx3-expressing cells will provide a novel strategy
to conditionally generate excitatory glutamatergic neurons in
vivo. Consistent with this, 50%–75% of mouse ESCs overex-
pressing Ngn1 were shown to differentiate into neurons with
a glutamatergic phenotype in deafened guinea pig’s cochleae
[53]. As our results indicate that Tlx3 controls Ngn1 expres-
sion in MSCs, stimulating the Tlx3-Ngn1 pathway would
likely yield stem cell-derived neurons to replace auditory neu-
rons in the inner ear. Further investigation is required to
determine the optimal conditions for neural induction from
embryonic and somatic stem cells in vivo.
CONCLUSION
We have identified Tlx3 as a novel target for the canonical
Wnt signaling that promotes neuronal differentiation from
bone marrow-derived somatic stem cells. TCF3/4, Wnt-acti-
vated DNA binding proteins, interact with a regulatory region
of Tlx3 in neurally induced MSCs and a mutation in the TCF-
binding motif reduces Wnt-dependent Tlx3 promoter activity.
Thus, Wnt-induced acquisition of a sensory neuron phenotype
in neurally induced MSCs appears to be mediated by Tlx3. In
addition, Wnt1 promotes engraftment and survival of trans-
planted MSCs in the inner ear of animals bearing selective
loss of sensory neurons. These results suggest that activating
the Wnt-Tlx3 pathway could confer neurally competent MSCs
with a sensory neuron phenotype and promote their survival.
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